Both supplements can have some side effects
[11] [56] In December 2024, the FDA approved tirzepatide (Zepbound) as the first medication to be used in the treatment of moderate to severe obstructive sleep apnea
These often improve as the body adjusts, but some people may experience persistent gastrointestinal discomfort
Please note: These products are not intended to diagnose, treat, cure, or prevent any disease
This has opened the door to many people who struggled with unsuccessful weight loss attempts
Collaborative efforts across research, clinical, and pharmaceutical domains are essential to translate these innovations into transformative therapies, ultimately improving outcomes for the global diabetes population, say the study authors